동물용 골이식편 및 골대체물 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 동물 유형별, 형태별, 용도별, 재료별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Veterinary Bone Grafts And Substitutes Market Growth & Trends:

The global veterinary bone grafts and substitutes market size is anticipated to reach USD 371.35 million by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 6.48% from 2025 to 2030. The market growth is primarily driven by the growing animal population and ownership rates, expenditure on animals, an focus on innovative and effective veterinary surgical procedures, advancements in veterinary bone grafts and substitutes, and growing R&D investment. For instance, in March 2024, TheraVet launched BIOCERA-VET Equine, a new line of bone substitutes for managing dental and orthopedic conditions in horses. This product offers unique properties for treating subchondral bone cysts and dental issues, addressing a significant need in equine veterinary care. BIOCERA-VET's advanced formulations, including injectable and granule options, aim to enhance outcomes in bone surgeries and provide effective alternatives for osteosarcoma management, impacting the market with its specialized solutions.

Furthermore, primary factors that lead to orthopedic problems in pets are obesity and poor nutrition. Obesity increases pressure on joints & bones. According to the Association for Pet Obesity Prevention's (APOP) 2023 survey, 59% of dogs and 61% of cats were overweight or obese in the U.S. in 2022. In the U.S., Canada, and Europe, an estimated 63% of pet cats and 59% of pet dogs are overweight or obese. Similarly, according to the American Association of Equine Practitioners, in 2022, around 51% of horses had a Body Condition Score (BCS) greater than 6, which is considered overweight, and around 19% of the 50% had a BCS of 8 to 9, which is considered obese.

Additionally, the rising prevalence of osteoarthritis and cruciate ligament injuries in animals is increasing because of obesity & other lifestyle conditions, which is boosting demand for veterinary orthopedic devices and surgeries such as bone grafts and substitutes. Moreover, the rising amount of osteoarthritis among canines is anticipated to fuel market growth. For instance, in 2022, according to the National Center for Biotechnology Information, a veterinarian confirmed the diagnosis of osteoarthritis in 38% (188 of 500) of dogs. Hence, obesity and the prevalence of osteoarthritis among canine & feline are resulting in orthopedic problems, which, in turn, is driving the need for various advanced treatments for orthopedic problems like veterinary bone grafting procedures.

Veterinary Bone Grafts And Substitutes Market Report Highlights:

• By product, the autografts segment dominated market with a share of over 41.63% in 2024. However, Others segment is expected to grow at fastest CAGR during forecast period due to 7.4%. Other synthetic bone grafts and substitutes particularly those made from materials like tricalcium phosphate (TCP) and hydroxyapatite, are gaining popularity in recent years. These synthetic options are favored due to their biocompatibility, ease of availability, and lower risk of disease transmission than allografts and autografts.
• In terms of animal type, the dog segment will dominate market in 2024 with a market share of 57.30%. The increasing prevalence of orthopedic injuries in dogs participating in agility competitions is expected to be one of the key factors driving the market due to the growing need for specialized care. However, Cats segment is expected to be fastest-growing segment with the highest CAGR of 7.8% over the forecast period.
• Based on form, the injectables segment held the largest share of 35.19% in 2024. In the veterinary bone grafts and substitutes market, injectable forms are increasingly popular due to their minimally invasive nature, which reduces surgical trauma and post-operative recovery time. However, Pellets segment is estimated to grow at the highest CAGR of 7.5% over the forecast period. Pellet forms are gaining popularity due to their ease of handling and precise placement.
• By application, the orthopedic segment held highest share of 41.78% in 2024. Veterinary bone grafts and substitutes are commonly used in orthopedic treatments compared to other indications. On other hand, Dental segment is expected to grow at the highest CAGR of 7.3% over the forecast period due to their effectiveness in treating periodontal disease, jaw fractures, and bone defects caused by dental extractions or tumors.
• Based on material, the tricalcium phosphate (TCP) segment is dominating market in 2024 with a market share of 41.07%. The demand for Tricalcium Phosphate (TCP) based veterinary bone grafts and substitutes is higher due to TCP's excellent biocompatibility and osteoconductive properties, which promote natural bone regeneration. However, Bioglass segment is expected to be fastest-growing segment with the highest CAGR of 7.8% over the forecast period
• Based on end use, the veterinary hospitals & clinics segment held the largest share of 90.62% in 2024 and is expected to grow at highest CAGR of 6.7% during forecast period. The veterinary hospitals and clinics segment held the largest share due to their extensive use of these products for a wide range of orthopedic procedures.
• By region, North America held the largest share of about 45.73% in 2024. Conversely, Asia Pacific region is anticipated to grow fastest at about 7.77% in coming years.
• Increased awareness among pet owners and veterinarians about the benefits of bone grafts and substitutes and progress in regenerative medicine, including stem cell therapies and growth factor applications, supports the adoption of advanced bone grafting techniques in veterinary medicine.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information/Data Analysis
• 1.5. Market Formulation & Visualization
• 1.6. Data Validation & Publishing
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis
  • 1.7.2. Global Market: CAGR Calculation
• 1.8. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Veterinary Bone Grafts & Substitutes Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Rising Prevalence Of Diseases in Animals
    • 3.2.1.2. Growing Advancement In Veterinary Bone Surgery
    • 3.2.1.3. Growing Pet Insurance Coverage
    • 3.2.1.4. Supportive Initiatives
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. Lack Of Standard Regulations
    • 3.2.2.2. Shortage Of Board-Certified Veterinarians.
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenges Analysis
• 3.3. Veterinary Bone Grafts & Substitutes Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental Landscape
    • 3.3.2.5. Legal landscape
• 3.4. Pricing Analysis, 2024
• 3.5. Covid-19 Analysis
• 3.6. Technology Timeline Overview
• 3.7. Estimated Pet Population, by key countries

Chapter 4. Veterinary Bone Grafts & Substitutes Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Veterinary Bone Grafts & Substitutes Market Movement Analysis
• 4.3. Global Veterinary Bone Grafts & Substitutes Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Autografts
  • 4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.5. Allografts
  • 4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.6. Xenografts
  • 4.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.7. Others
  • 4.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Veterinary Bone Grafts & Substitutes Market: Animal Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Veterinary Bone Grafts & Substitutes Market Movement Analysis
• 5.3. Global Veterinary Bone Grafts & Substitutes Market Size & Trend Analysis, by Animal Type, 2018 to 2030 (USD Million)
• 5.4. Dogs
  • 5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.5. Cats
  • 5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.6. Horses
  • 5.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Veterinary Bone Grafts & Substitutes Market: Form Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Veterinary Bone Grafts & Substitutes Market Movement Analysis
• 6.3. Global Veterinary Bone Grafts & Substitutes Market Size & Trend Analysis, by Form, 2018 to 2030 (USD Million)
• 6.4. Powders
  • 6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.5. Putty
  • 6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.6. Pellets
  • 6.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.7. Injectables
  • 6.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.8. Others
  • 6.8.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Veterinary Bone Grafts & Substitutes Market: Application Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Veterinary Bone Grafts & Substitutes Market Movement Analysis
• 7.3. Global Veterinary Bone Grafts & Substitutes Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 7.4. Orthopedic
  • 7.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.5. Dental
  • 7.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.6. Ocular
  • 7.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.7. Osteosarcoma
  • 7.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.8. Other Application
  • 7.8.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Veterinary Bone Grafts & Substitutes Market: Material Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global Veterinary Bone Grafts & Substitutes Market Movement Analysis
• 8.3. Global Veterinary Bone Grafts & Substitutes Market Size & Trend Analysis, by Material, 2018 to 2030 (USD Million)
• 8.4. Tricalcium Phosphate (TCP)
  • 8.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.5. Ceramic
  • 8.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.6. Bioglass
  • 8.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.7. Others
  • 8.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. Veterinary Bone Grafts & Substitutes Market: End Use Estimates & Trend Analysis

• 9.1. Segment Dashboard
• 9.2. Global Veterinary Bone Grafts & Substitutes Market Movement Analysis
• 9.3. Global Veterinary Bone Grafts & Substitutes Market Size & Trend Analysis, End Use, 2018 to 2030 (USD Million)
• 9.4. Veterinary Hospitals & Clinics
  • 9.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
• 9.5. Others
  • 9.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 10. Veterinary Bone Grafts & Substitutes Market: Regional Estimates & Trend Analysis

• 10.1. Regional Dashboard
• 10.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030 North America
• 10.3. North America
  • 10.3.1. U.S.
    • 10.3.1.1. Key country dynamics
    • 10.3.1.2. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.3.2. Canada
    • 10.3.2.1. Key country dynamics
    • 10.3.2.2. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.3.3. Mexico
    • 10.3.3.1. Key country dynamics
    • 10.3.3.2. Mexico. market estimates and forecasts 2018 to 2030 (USD Million)
• 10.4. Europe
  • 10.4.1. U.K.
    • 10.4.1.1. Key country dynamics
    • 10.4.1.2. Europe market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.4.2. Germany
    • 10.4.2.1. Key country dynamics
    • 10.4.2.2. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.4.3. France
    • 10.4.3.1. Key country dynamics
    • 10.4.3.2. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.4.4. Italy
    • 10.4.4.1. Key country dynamics
    • 10.4.4.2. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.4.5. Spain
    • 10.4.5.1. Key country dynamics
    • 10.4.5.2. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.4.6. Sweden
    • 10.4.6.1. Key country dynamics
    • 10.4.6.2. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.4.7. Denmark
    • 10.4.7.1. Key country dynamics
    • 10.4.7.2. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.4.8. Norway
    • 10.4.8.1. Key country dynamics
    • 10.4.8.2. Norway market estimates and forecasts 2018 to 2030 (USD Million)
• 10.5. Asia Pacific
  • 10.5.1. Japan
    • 10.5.1.1. Key country dynamics
    • 10.5.1.2. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.5.2. China
    • 10.5.2.1. Key country dynamics
    • 10.5.2.2. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.5.3. India
    • 10.5.3.1. Key country dynamics
    • 10.5.3.2. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.5.4. Australia
    • 10.5.4.1. Key country dynamics
    • 10.5.4.2. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.5.5. South Korea
    • 10.5.5.1. Key country dynamics
    • 10.5.5.2. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.5.6. Thailand
    • 10.5.6.1. Key country dynamics
    • 10.5.6.2. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.5.7. Rest of Asia-Pacific
    • 10.5.7.1. Key country dynamics
    • 10.5.7.2. Rest of Asia-Pacific market estimates and forecasts 2018 to 2030 (USD Million)
• 10.6. Latin America
  • 10.6.1. Brazil
    • 10.6.1.1. Key country dynamics
    • 10.6.1.2. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.6.2. Argentina
    • 10.6.2.1. Key country dynamics
    • 10.6.2.2. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 10.7. MEA
  • 10.7.1. South Africa
    • 10.7.1.1. Key country dynamics
    • 10.7.1.2. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.7.2. Saudi Arabia
    • 10.7.2.1. Key country dynamics
    • 10.7.2.2. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.7.3. UAE
    • 10.7.3.1. Key country dynamics
    • 10.7.3.2. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 10.7.4. Kuwait
    • 10.7.4.1. Key country dynamics
    • 10.7.4.2. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 11. Competitive Landscape

• 11.1. Market Participant Categorization
• 11.2. Company Market Position Analysis/ Heat Map Analysis
• 11.3. Estimated Company Market Share Analysis, 2024
• 11.4. Strategy Mapping
  • 11.4.1. Mergers & Acquisitions
  • 11.4.2. Partnerships & Collaborations
  • 11.4.3. Others
• 11.5. Company Profiles
  • 11.5.1. Movora (Vimian Group AB)
    • 11.5.1.1. Participant's Overview
    • 11.5.1.2. Financial Performance
    • 11.5.1.3. Product Benchmarking
    • 11.5.1.4. Strategic Initiatives
  • 11.5.2. TheraVet SA
    • 11.5.2.1. Participant's Overview
    • 11.5.2.2. Financial Performance
    • 11.5.2.3. Product Benchmarking
    • 11.5.2.4. Strategic Initiatives
  • 11.5.3. Biomendex
    • 11.5.3.1. Participant's Overview
    • 11.5.3.2. Financial Performance
    • 11.5.3.3. Product Benchmarking
    • 11.5.3.4. Strategic Initiatives
  • 11.5.4. Integra LifeSciences Corporation.
    • 11.5.4.1. Participant's Overview
    • 11.5.4.2. Financial Performance
    • 11.5.4.3. Product Benchmarking
    • 11.5.4.4. Strategic Initiatives
  • 11.5.5. Progenica Therapeutics, LLC.
    • 11.5.5.1. Participant's Overview
    • 11.5.5.2. Financial Performance
    • 11.5.5.3. Product Benchmarking
    • 11.5.5.4. Strategic Initiatives
  • 11.5.6. BioChange
    • 11.5.6.1. Participant's Overview
    • 11.5.6.2. Financial Performance
    • 11.5.6.3. Product Benchmarking
    • 11.5.6.4. Strategic Initiatives
  • 11.5.7. Nutramax Laboratories Veterinary Sciences, Inc.
    • 11.5.7.1. Participant's Overview
    • 11.5.7.2. Financial Performance
    • 11.5.7.3. Product Benchmarking
    • 11.5.7.4. Strategic Initiatives
  • 11.5.8. RITA LEIBINGER GmbH & Co. KG.
    • 11.5.8.1. Participant's Overview
    • 11.5.8.2. Financial Performance
    • 11.5.8.3. Product Benchmarking
    • 11.5.8.4. Strategic Initiatives
  • 11.5.9. VETEREGEN
    • 11.5.9.1. Participant's Overview
    • 11.5.9.2. Financial Performance
    • 11.5.9.3. Product Benchmarking
    • 11.5.9.4. Strategic Initiatives
  • 11.5.10. AlphaLogix, LLC
    • 11.5.10.1. Participant's Overview
    • 11.5.10.2. Financial Performance
    • 11.5.10.3. Product Benchmarking
    • 11.5.10.4. Strategic Initiatives
• 11.6. List of Other Market Players